Answers are grounded in this paper and cite their sources.
Oligochitosan was used in this study to glycate commercial caseinate under the catalytic action of transglutaminase (TGase), followed by trypsin-mediated digestion. The prepared tryptic digests from both caseinate and oligochitosan-glycated caseinate were assessed and compared for their effects on the intestinal barrier function of a cell model (IEC-6 cells). Both digests had similar chemical features in the nine amino acids (except for Met) and free amino group contents, but had different glucosamine contents. Both digests at 12.5-100 μg mL-1 promoted IEC-6 cell growth by 105.6-135.1% and more importantly improved intestinal epithelial barrier integrity via increasing trans-epithelial electrical resistance, decreasing paracellular permeability from 100% to 64.1-85.4%, reducing bacterial translocation, and enhancing antibacterial activity against Escherichia coli. The obtained qPCR and western-blot assay results also demonstrated that both digests had promoting effects on the expression levels of several tight junction proteins such as ZO-1, occludin, and claudin-1. The oligochitosan-glycated caseinate digest always showed higher effects than the caseinate digest in the cells to retain the intestinal epithelial barrier function. This study thus highlights that the used TGase-type glycation endowed the oligochitosan-glycated caseinate with a potential functional food ingredient to strengthen the epithelial barrier function, which might be a helpful event to intestinal health.
No takes yet. Share an insight, caveat, or question.
Shi et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: